Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal of Cellular Biochemistry
|
May 13, 1999
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix
L M Neri, R Bortul, M Zweyer, et al.
Leukemia
|
February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation
R Bortul, P L Tazzari, A Cappellini, et al.
Leukemia
|
September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells
A M Martelli, P L Tazzari, G Tabellini, et al.
Leukemia
|
March 16, 2007
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion
P L Tazzari, G Tabellini, R Bortul, et al.
Transfusion
|
February 24, 2000
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients
A M Martelli, P L Tazzari, R Bortul, et al.
Leukemia
|
July 30, 2013
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential
L M Neri, A Cani, A M Martelli, et al.
Leukemia
|
February 19, 2011
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
C Evangelisti, F Ricci, P Tazzari, et al.
Leukemia
|
October 5, 2011
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications
C Grimaldi, F Chiarini, G Tabellini, et al.
Leukemia
|
May 23, 2012
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
C Simioni, L M Neri, G Tabellini, et al.
Leukemia
|
November 21, 2013
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling
F Buontempo, E Orsini, L R Martins, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal of Cellular Biochemistry
|
May 13, 1999
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix
L M Neri, R Bortul, M Zweyer, et al.
Leukemia
|
February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation
R Bortul, P L Tazzari, A Cappellini, et al.
Leukemia
|
September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells
A M Martelli, P L Tazzari, G Tabellini, et al.
Leukemia
|
March 16, 2007
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion
P L Tazzari, G Tabellini, R Bortul, et al.
Transfusion
|
February 24, 2000
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients
A M Martelli, P L Tazzari, R Bortul, et al.
Leukemia
|
July 30, 2013
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential
L M Neri, A Cani, A M Martelli, et al.
Leukemia
|
February 19, 2011
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
C Evangelisti, F Ricci, P Tazzari, et al.
Leukemia
|
October 5, 2011
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications
C Grimaldi, F Chiarini, G Tabellini, et al.
Leukemia
|
May 23, 2012
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
C Simioni, L M Neri, G Tabellini, et al.
Leukemia
|
November 21, 2013
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling
F Buontempo, E Orsini, L R Martins, et al.
Page
of 3